← Oncology Approval Tracker

FDA DECISION ·

Rybrevant

amivantamab-vmjw · Janssen Biotech

Traditional approvalTraditional conversionNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with locally advanced or metastatic non-small cell lung cancer with an FDA test-confirmed EGFR exon 20 insertion and progression on or after platinum chemotherapy.

LAMPGEN ANALYSIS

Why it matters

The FDA converted the post-platinum single-agent indication alongside a separate first-line combination approval.

What research teams should watch

Distinguish single-agent dosing and prior platinum eligibility from the newly approved frontline regimen.

PRIMARY RECORDS

Sources